Dr. Josh Denny, M.D., M.S. - CEO, All of Us Research Program, National Institutes of Health (NIH) - Accelerating Health Research And Medical Breakthroughs, Enabling Individualized Prevention, Treatment And Care

Send us Fan MailDr. Josh Denny, M.D., M.S., is the Chief Executive Officer (CEO) of the National Institutes of Health’s All of Us Research Program ( https://allofus.nih.gov/about/who-we-are/joshua-denny ), an initiative that seeks to enroll at least one million diverse participants to build an indispensable resource that accelerates precision medicine for all populations. Dr. Denny has been involved since the program’s inception when he was a member of the NIH Precision Medicine Initiative Working Group of the Advisory Committee to the Director ( https://allofus.nih.gov/about/who-we-are/pmi-working-group-advisory-committee-director ), which developed the program’s initial scientific blueprint and he then led the program’s initial prototyping project and the All of Us Data and Research Center. He was named CEO of All of Us in January 2020. Before joining NIH, Dr. Denny was a practicing physician and held several leadership positions at Vanderbilt University Medical Center, including professor of biomedical informatics and medicine, founding director of the Center for Precision Medicine, and vice president for personalized medicine. At Vanderbilt, he led discovery and implementation projects in precision medicine, including clinical pharmacogenomics and Vanderbilt’s DNA biobank. He was a pioneer in the use of electronic health records for genomics studies, including the initial descriptions of phenome‐wide association studies and phenotype risk scores. Dr. Denny is an elected member of the National Academy of Medicine, the American Society for Clinical Investigation, and the American College of Medical Informatics. Dr. Denny has a Medical Degree, and a Master’s Degree in Biomedical Informatics, from Vanderbilt University School of Medicine. Support the show